HealthPartners Institute
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, HealthPartners Institute sits in the top decile of US sponsors by registered trial count (#191 of 15,742 sponsors by registered trial count).
HealthPartners Institute: 146 sponsored US clinical trials, 12 recruiting.
HealthPartners Institute sponsors 146 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 111 completed. 11 of these trials are in Phase 3-4 (later-stage) and 19 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 3 trials.
Top-decile sponsor footprint
HealthPartners Institute ranks in the top decile of sponsors by registered trial count (#191 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
111 of 126 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
146 total, page 1 of 3
Axelopran for Advanced Cancer in Patients Receiving Opioids
NCT07354919
Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury
NCT07384052
Cannabis Use Registry to Improve Overall Understanding of Symptoms (CURIOUS)
NCT07227324
Irrigating vs Traditional Negative Pressure Wound Therapy to Treat Necrotizing Soft Tissue Infections
NCT07120386
Utilizing 3D Imaging for Burn Wound Assessment
NCT06938061
ACL Reconstruction Rehabilitation With Exercise and Psychological Support
NCT06991192
Novel Post-Surgical Incision Management to Prevent Ostomy Complications
NCT06524401
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
NCT06491238
Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
NCT06605430
Geriatric Lateral Compression 1 Pelvic Fractures
NCT05765669
Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)
NCT07107607
Rehabilitation Following Reverse Total Shoulder Arthroplasty
NCT03804853
Mindfulness-Based Stress Reduction for Emotional Recovery After Stroke
NCT07491861
Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib
NCT06083038
Weight Loss Clinical Decision Support
NCT05198765
Comparison of ICG Microangiography and Conventional Angiography in Severe Frostbite
NCT05777590
Glucose Monitoring Comparison in Primary Care
NCT05222815
An Insole and Ankle Device for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)
NCT07127133
Reducing Risk of Diabetic Ketoacidosis in Type 1 Diabetes and Kidney Disease Using Continuous Ketone Monitoring
NCT07325201
The Effect of the Safe and Sound Protocol on Depression and Anxiety Symptoms
NCT06701578
HeartBeet Clinic Pilot Trial
NCT06486532
Continuous Wearable Monitor for the Detection and Release of Freezing of Gait.
NCT06385392
Hepatitis C Lab Testing Comparison Study
NCT06380166
Transmagnetic Stimulation Pilot in Primary Progressive Aphasia
NCT05860647
A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment
NCT05723523
Measurement of Insulin Levels in Cerebral Spinal Fluid (CSF) of Healthy Adults After a Single Intranasal Dose
NCT05866367
Nutrition-Focused Approach During CGM Initiation: A Qualitative Study
NCT05988957
Mindfulness-based Dementia Care Partner Program to Reduce Depressive Symptoms
NCT05617300
MAP to Health Pilot Study: A Physical Activity Intervention for Midlife Adults
NCT05332145
Do Generic Volar Locking Plates Provide Similar Outcomes at a Reduced Cost?
NCT06343467
IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE)
NCT05516797
Outreach-ER: A Dementia Care Intervention Program
NCT05451693
Pediatric Blood Pressure Clinical Decision Support Tool (PedsBP CDS)
NCT05126082
Transmagnetic Stimulation Pilot in Early Stage Alzheimer's Disease
NCT05292222
Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis
NCT06007508
Acupuncture in Myasthenia Gravis (AcuMG)
NCT05230082
Spinal Cord Injury - Exercise
NCT05376449
Firefighter Soot, Sauna, and Sweat Excretion Pilot Study
NCT05256966
Suicide Prediction and Prevention for People at Risk for Opioid Use Disorder: Supplement to COMPUTE 2.0
NCT04939727
Minnesota Care Coordination Effectiveness Study
NCT04957979
Dementia With Lewy Bodies - Infinitome
NCT04773041
Comparing Two Training Methods for Opioid Wizard
NCT04867382
Impact of Colchicine and Low-dose Naltrexone on COVID-19
NCT04756128
Acupuncture in Traumatic Brain Injury
NCT04369911
Feasibility - Infinitome
NCT04563767
Medication Adherence Clinical Decision Support
NCT03748420
De-Implementing Opioids for Dental Extractions
NCT03584789
Intranasal Insulin in Parkinson's Disease
NCT04251585
Post-Operative Cognitive Dysfunction in Normal Aging Patients Undergoing Elective Orthopedic Surgery
NCT04267328
Clinical Decision Support for Opioid Use Disorders in Medical Settings (COMPUTE 2.0)
NCT04198428
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 12 |
| Phase 3 | 1 |
| Phase 4 | 10 |
What is open in the HealthPartners Institute pipeline
12 recruiting of 146 indexed (8% open); 111 completed (76%).
Phase mix: 11 late (III/IV) vs 19 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
HealthPartners Institute: open-pipeline peers nationwide
Peers matched on 146 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
HealthPartners Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 146 trials (± recruiting share)
- Mylan Pharmaceuticals · 146 trials · 1% recruiting
- SCRI Development Innovations · 146 trials · 3% recruiting
- Forest Laboratories · 145 trials · 0% recruiting
- National Institute of Environmental Health Sciences (NIEHS) · 145 trials · 10% recruiting
Sponsors near 8% open enrollment (± trial volume)
- National Eye Institute (NEI) · 8% recruiting · 221 trials
- Acrotech Biopharma · 8% recruiting · 24 trials
- Atlanta VA Medical Center · 8% recruiting · 12 trials
- Beacon Therapeutics · 8% recruiting · 12 trials
Related
What to do with this HealthPartners Institute page
146 registered trials is a research-attention snapshot, not an endorsement of HealthPartners Institute or any single study.
- 12 of HealthPartners Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition HealthPartners Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
HealthPartners Institute pipeline card: 146 registered trials from official public datasets.Report a data error.